Orchestra BioMed Holdings, Inc. (OBIO) Operating cash flow 2021–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$49.0MFY2025 · since FY2021: -$272,362 → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | +3.2% |
| FY2024 | -$50.6M | -9.6% |
| FY2023 | -$46.1M | -57.5% |
| FY2022 | -$29.3M | -10653.7% |
| FY2021 | -$272,362 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →